- Home
- XTNT vs RMCO Comparison
XTNT vs RMCO Comparison
Compare XTNT & RMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XTNT | RMCO |
|---|---|---|
| Founded | N/A | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Multi-Sector Companies |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.6M | 35.2M |
| IPO Year | 2009 | 2021 |
Fundamental Metrics
Financial Performance| Metric | XTNT | RMCO |
|---|---|---|
| Price | $0.28 | $2.38 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $1.03 | N/A |
| AVG Volume (30 Days) | ★ 90.9K | 7.8K |
| Earning Date | 11-13-2026 | 11-12-2026 |
| Dividend Yield | N/A | ★ 0.43% |
| EPS Growth | ★ 125.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $53,337,000.00 | $4,949,916.00 |
| Revenue This Year | N/A | $61.62 |
| Revenue Next Year | $10.85 | $62.50 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 513.30 |
| 52 Week Low | $0.27 | $1.74 |
| 52 Week High | $0.89 | $5.00 |
Technical Indicators
Market Signals| Indicator | XTNT | RMCO |
|---|---|---|
| Relative Strength Index (RSI) | 37.79 | 44.45 |
| Support Level | $0.28 | $2.11 |
| Resistance Level | $0.49 | $2.46 |
| Average True Range (ATR) | 0.02 | 0.12 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 12.98 | 43.59 |
Price Performance
Historical ComparisonAbout XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
About RMCO Royalty Management Holding Corporation
Royalty Management Holding Corp is formed to invest or purchase assets that have near and medium-term income potential to provide RMC with accretive cash flow from which it can reinvest in new assets or expand cash flow from those existing assets. These assets typically are natural resources assets (including real estate and mining permits), patents, intellectual property, and emerging technologies.